XTX Topco’s Inhibrx, Inc. Common Stock INBX Stock Holding History

XTX Topco’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,368	Closed	-$300K	–	2338
2023 Q3	$300K	Buy	+16,368	New	+$342K	0.05%	730

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

XTX Topco's INBX Position: Q4 2023 in Review

XTX Topco sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2023, closing a stake of 16,368 shares — an estimated $300K sold.

XTX Topco first reported a position in INBX in Q3 2023 and held it in 1 quarter. The position peaked at $300K in Q3 2023. 127 funds tracked by Wall St. Rank hold INBX as of Q4 2023.

XTX Topco reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
XTX Topco sold 16,368 Inhibrx, Inc. Common Stock shares in Q4 2023, an estimated $300K.
XTX Topco first reported a position in Inhibrx, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
XTX Topco's Inhibrx, Inc. Common Stock position peaked at $300K in Q3 2023.
127 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2023.

Based on XTX Topco's 13F filing for Q4 2023, filed 13 Feb 2024.